Highlights
Profile claimed by owner
About
Oral Drug Delivery System for Controlled Release (CR) of Lipophilic Drugs
BSD SCIENCE is a biotech company that has developed a unique oral dosage form designed for controlled release (CR) of lipophilic drugs, in order to achieve long duration of effect, less adverse effects and higher compliance to treatment.
The platform is suitable for lipophilic molecules used in the Medical Cannabis, Pharma industry and Dietary Supplement markets. During 2022, the company completed a POC PK animals study, where promising results were achieved, and U.S. Provisional Patent Application was submitted. BSD SCIENCE plans to move on towards human PK study.
Identity
| Name | BSD SCIENCE |
|---|---|
| Slug | bsd-science |
| Type / kind | startup |
| Source _id | MF4lpfC1tu6splRHVDZWEN1OVymHZxifPFTI7dJ0UIdlGzqPvN5e1o |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Tel Aviv-Yafo, Israel |
Web & social
| https://www.linkedin.com/company/96453492 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
pharmaceuticalsbiotechnologydrug-deliverytreatmentsmedical-cannabis
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}